文献速递牙周病

CCL2是牙周炎的关键调控因子及治疗靶点

CCL2 is a key regulator and therapeutic target for periodontitis.
PubMed 文献 · J Clin Periodontol · 2023-09-11

本研究基于人样本、CCL2基因敲除小鼠及牙周过表达模型,发现CCR2的配体中仅CCL2在牙周炎牙龈组织显著上调并与病情严重程度正相关。CCL2缺失减轻炎症和骨吸收,局部给予CCL2合成抑制剂bindarit可抑制破骨细胞数和骨丧失,提示靶向CCL2是控制牙周炎的可行策略。

要点

  • CCL2在牙周炎牙龈组织中显著上调,且与病情严重程度正相关。
  • CCL2缺失可减轻小鼠牙周炎症、单核/巨噬细胞募集及骨吸收。
  • 局部应用bindarit抑制CCL2合成,减少破骨细胞数和骨丧失。

核心结论

  • CCL2是牙周炎进展中与CCR2结合的关键趋化因子,靶向CCL2可能是控制牙周炎的可行选择。

研究设计与样本

  • 研究使用人样本评估CCR2及CCL2、CCL7、CCL8、CCL13、CCL16的表达与临床相关性。
  • 采用CCL2基因敲除小鼠及牙周过表达CCL2模型评估CCL2在牙周炎中的作用。
  • 在小鼠牙周炎模型中通过预防性和治疗性给药评估局部应用bindarit的效果。

主要发现

  • CCR2的配体中仅CCL2在牙周炎牙龈组织显著上调,并与牙周炎严重程度正相关。
  • CCL2缺失小鼠较野生型小鼠炎症更轻、骨吸收更少,伴单核/巨噬细胞募集减少。
  • 在Ccl2-/-小鼠牙龈过表达CCL2可以CCR2依赖方式逆转牙周炎减轻。
  • 结扎诱导实验性牙周炎中,预防或治疗性给予bindarit显著抑制CCL2产生、减少破骨细胞数和骨丧失。
  • Bindarit降低促炎细胞因子TNF-α、IL-6和IL-1β的表达水平。

临床怎么用

  • 靶向CCL2可能作为控制牙周炎的潜在治疗方向,bindarit局部给药在动物模型中显示预防和治疗效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Our previous study revealed that the C-C motif chemokine receptor 2 (CCR2) is a promising target for periodontitis prevention and treatment. However, CCR2 is a receptor with multiple C-C motif chemokine ligands (CCLs), including CCL2, CCL7, CCL8, CCL13 and CCL16, and which of these ligands plays a key role in periodontitis remains unclear. The aim of the present study was to explore the key functional ligand of CCR2 in periodontitis and to evaluate the potential of the functional ligand as a therapeutic target for periodontitis. MATERIALS AND METHODS: The expression levels and clinical relevance of CCR2, CCL2, CCL7, CCL8, CCL13 and CCL16 were studied using human samples. The role of CCL2 in periodontitis was evaluated by using CCL2 knockout mice and overexpressing CCL2 in the periodontium. The effect of local administration of bindarit in periodontitis was evaluated by preventive and therapeutic medication in a mouse periodontitis model. Microcomputed tomography, haematoxylin and eosin staining, tartrate-resistant acid phosphatase staining, real-time quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, bead-based immunoassays and flow cytometry were used for histomorphology, molecular biology and cytology analysis. RESULTS: Among different ligands of CCR2, only CCL2 was significantly up-regulated in periodontitis gingival tissues and was positively correlated with the severity of periodontitis. Mice lacking CCL2 showed milder inflammation and less bone resorption than wild-type mice, which was accompanied by a reduction in monocyte/macrophage recruitment. Adeno-associated virus-2 vectors overexpressing CCL2 in Ccl2-/- mice gingiva reversed the attenuation of periodontitis in a CCR2-dependent manner. In ligation-induced experimental periodontitis, preventive or therapeutic administration of bindarit, a CCL2 synthesis inhibitor, significantly inhibited the production of CCL2, decreased the osteoclast number and bone loss and reduced the expression levels of proinflammatory cytokines TNF-α, IL-6 and IL-1β. CONCLUSIONS: CCL2 is a pivotal chemokine that binds to CCR2 during the progression of periodontitis, and targeting CCL2 may be a feasible option for controlling periodontitis.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Jiang W, Xu T, Song Z, et al. CCL2 is a key regulator and therapeutic target for periodontitis. J Clin Periodontol. 2023. PMID: 37697486. doi:10.1111/jcpe.13872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。